Akihiro Sekine

Akihiro Sekine

Auto-generated profile, based on publicly available information

Akihiro Sekine

Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RNRyosuke Nakamura
Ryosuke Nakamura
TOTakeshi Ozeki
Takeshi Ozeki
NHNoriaki Hirayama
Noriaki Hirayama
ASAkihiro Sekine
Akihiro Sekine
TYTaiki Yamashita
Taiki Yamashita
EMEishin Morita
Eishin Morita

28 August 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
HTHaruhiko Takeda
Haruhiko Takeda
TYTaiki Yamashita
Taiki Yamashita
YUYoshihide Ueda
Yoshihide Ueda
ASAkihiro Sekine
Akihiro Sekine
Single molecular real-time (SMRT) sequencing, also called third-generation sequencing, is a novel sequencing technique capable of generating extremely long contiguous sequence reads. While conventional short-read sequencing cannot evaluate the linkage of nucleotide substitutions distant from one another, SMRT sequencing can directly demonstrate linkage of nucleotide changes over a span of more than 20 kbp, and thus can be applied to directly examine the haplotypes of viruses or bacteria whose genome structures are changing in real time. In addition, an error correction method (circular consensus sequencing) has been established and repeated sequencing of a single-molecule DNA template can result in extremely high accuracy. The advantages of long read sequencing enable accurate determination of the haplotypes of individual viral clones. SMRT sequencing has been applied in various studies of viral genomes including determination of the full-length contiguous genome sequence of hepatitis C virus (HCV), targeted deep sequencing of the HCV NS5A gene, and assessment of heterogeneity among viral populations. Recently, the emergence of multi-drug resistant HCV viruses has become a significant clinical issue and has been also demonstrated using SMRT sequencing. In this review, we introduce the novel third-generation PacBio RSII/Sequel systems, compare them with conventional next-generation sequencers, and summarize previous studies in which SMRT sequencing technology has been applied for HCV genome analysis. We also refer to another long-read sequencing platform, nanopore sequencing technology, and discuss the advantages, limitations and future perspectives in using these third-generation sequencers for HCV genome analysis.

14 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TYTaiki Yamashita
Taiki Yamashita
HTHaruhiko Takeda
Haruhiko Takeda
ATAtsushi Takai
Atsushi Takai
SASoichi Arasawa
Soichi Arasawa
FNFumiyasu Nakamura
Fumiyasu Nakamura
ASAkihiro Sekine
Akihiro Sekine
While direct-acting antivirals (DAAs) for hepatitis C virus (HCV) have dramatically progressed, patients still suffer from treatment failures. For the radical eradication of HCV, a deeper understanding of multiple resistance-associated substitutions (RASs) at the single-clone level is essential. To understand HCV quasispecies and their dynamics during DAA treatment, we applied single-molecule real-time (SMRT) deep sequencing on sera from 12 patients with genotype-1b HCV infections with DAA treatment failures, both pre- and post-treatment. We identified >3.2 kbp sequences between NS3 and NS5A genes of 187,539 clones in total, classifying into haplotype codes based on the linkage of seven RAS loci. The number of haplotype codes during the treatment, per sample, significantly decreased from 14.67 ± 9.12 to 6.58 ± 7.1, while the number of nonsynonymous codons on the seven RAS loci, per clone, significantly increased from 1.50 ± 0.92 to 3.64 ± 0.75. In five cases, the minority multi-drug resistant haplotypes at pre-treatment were identical to the major haplotypes at relapse. Moreover, various structural variations (SVs) were detected and their dynamics analysed. These results suggest that SMRT deep sequencing is useful for detecting minority haplotypes and SVs, and to evaluate the dynamics of viral genomes at the single-clone level.

30 October 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KFKoya Fukunaga
Koya Fukunaga
ETEri Tsukagoshi
Eri Tsukagoshi
MKMaiko Kurata
Maiko Kurata
YMYoshiko Mizukawa
Yoshiko Mizukawa
HNHiroyuki Niihara
Hiroyuki Niihara
YSYoshiro Saito
Yoshiro Saito

23 December 2022 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
JSJunya Sato
Junya Sato
KNKazunari Nakahara
Kazunari Nakahara
YMYosuke Michikawa
Yosuke Michikawa
KSKeigo Suetani
Keigo Suetani
YIYosuke Igarashi
Yosuke Igarashi
KTKeisuke Tateishi
Keisuke Tateishi
Background: Endoscopic transpapillary gallbladder stenting (EGBS) is considered for patients with contraindications to early surgery for acute calculus cholecystitis. However, evidence regarding the long-term outcomes of EGBS is insufficient to date. The aim of the study was to evaluate the feasibility of EGBS as a bridge to or alternative to surgery when there are contraindications. Methods: We reviewed the cases of patients who underwent EGBS using a novel spiral-shaped plastic stent for acute calculus cholecystitis between January 2011 and December 2019. We retrospectively evaluated the long-term outcomes of EGBS using a novel spiral-shaped plastic stent. Results: Forty-nine patients were included. The clinical success rate of EGBS was 97%. After EGBS, 25 patients (surgery group) underwent elective cholecystectomy and 24 patients did not (follow-up group). In the surgery group, the median period from EGBS to surgery was 93 days. There was a single late adverse event with cholecystitis recurrence. In the follow-up group, the median follow-up period was 236 days. Late adverse events were observed in eight patients, including recurrence of cholecystitis (four patients), duodenal penetration by the distal stent end (two patients), and distal stent migration (two patient). In the follow-up group, the time to recurrence of biliary obstruction was 527 days. Conclusions: EGBS with a novel spiral-shaped plastic stent is safe and effective for long-term acute calculus cholecystitis. There is a possibility of EGBS to be a bridge to surgery and a surgical alternative for acute calculus cholecystitis in patients with contraindications to early cholecystectomy.

SNSachiko Nakagawa
Sachiko Nakagawa
YTYoshimitsu Takahashi
Yoshimitsu Takahashi
TNTakeo Nakayama
Takeo Nakayama
SMSHIGEO MURO
SHIGEO MURO
MMMichiaki Mishima
Michiaki Mishima
SKShinji Kosugi
Shinji Kosugi
Global tobacco policies lowered overall and male smoking rates, but female smoking rates have remained unchanged. Parent–child studies revealed the effects of parental smoking, but gender differences had mixed results. We investigated the effects of long-term smoking behavior in families over three generations in order to clarify gender differences. A cross-sectional study in a community-based genome cohort was conducted using a self-reported questionnaire. A total of 8652 respondents were stratified by gender regarding smoking initiation. A logistic regression analysis was performed to analyze the family smoking history. A total of 2987 current smokers and ever-smokers were compared regarding smoking cessation. With respect to smoking initiation, women were affected by their smoking mothers (odds ratio (OR), 2.4; 95% confidence interval (CI), 1.8–3.2) and grandmothers (OR, 1.7; CI, 1.1–2.4). Women who continued smoking were affected only by their smoking mothers (OR, 1.6; CI, 1.05–2.49). In conclusion, gender differences in smoking initiation and cessation are possibly associated with family smoking history. Mothers and grandmothers were shown to have a strong influence on women with respect to both smoking initiation and cessation. Future research should focus on providing evidence for effective gender-specific intervention programs to curb long-term smoking in women.